Power Law company profile

Clementia Pharmaceuticals

Biotech & Life Sciences · Montreal, Canada · Founded 2012 · IPO 2017 Unicorn

Developer of a drug to treat fibrodysplasia ossificans progressiva

Valuation

$1.31B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

6 investors on Clementia Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

OrbiMed

BDC Capital

Series B+ 4 investors entered at this stage

Fonds de solidarité FTQ

NEA

Rock Springs Capital

Janus Capital Group

Global footprint

Where Clementia Pharmaceuticals has talent and traffic

AI talent share

130.0% of workforce is AI talent
(13 of 10 staff)

Core AI330%

Other AI10100%

Non-AI workforce00%

Workforce by country

🇨🇦 Canada · Montreal HQ

Book a demo for the full country breakdown

Patent intelligence

$9M patent portfolio · 3 active families

Estimated portfolio value

$9M

0.70% of market cap · 773.3× smaller than top peer Janssen Vaccines ($7.1B)

3 active patent families

Where Clementia Pharmaceuticals innovates PalovarotenePharmacologyEndocrinologyDosing regimenActivin receptor

Where Clementia Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Clementia Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Clementia Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Clementia Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Clementia Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles